ZUDDAS, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 106.536
NA - Nord America 10.246
AS - Asia 4.792
SA - Sud America 715
AF - Africa 107
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 4
Totale 122.440
Nazione #
IT - Italia 102.292
US - Stati Uniti d'America 10.082
SG - Singapore 1.990
CN - Cina 1.546
NL - Olanda 1.159
UA - Ucraina 753
BR - Brasile 567
SE - Svezia 552
VN - Vietnam 446
FR - Francia 418
GB - Regno Unito 378
DE - Germania 359
FI - Finlandia 324
HK - Hong Kong 230
IN - India 132
CA - Canada 85
KR - Corea 78
RU - Federazione Russa 58
BD - Bangladesh 53
TR - Turchia 45
AR - Argentina 43
ZA - Sudafrica 41
AU - Australia 39
IQ - Iraq 39
MX - Messico 35
AT - Austria 31
ES - Italia 30
PK - Pakistan 26
PL - Polonia 26
CO - Colombia 25
CH - Svizzera 24
SA - Arabia Saudita 24
ID - Indonesia 23
EC - Ecuador 22
JP - Giappone 20
VE - Venezuela 20
PH - Filippine 19
BE - Belgio 17
MA - Marocco 17
AE - Emirati Arabi Uniti 15
IL - Israele 15
CL - Cile 14
UZ - Uzbekistan 14
DK - Danimarca 13
MY - Malesia 13
IE - Irlanda 12
IR - Iran 12
JO - Giordania 11
NO - Norvegia 11
RO - Romania 11
BO - Bolivia 10
GR - Grecia 10
CR - Costa Rica 9
ET - Etiopia 9
LT - Lituania 9
EG - Egitto 8
HN - Honduras 8
AL - Albania 7
DO - Repubblica Dominicana 7
TN - Tunisia 7
KE - Kenya 6
PT - Portogallo 6
PY - Paraguay 6
BA - Bosnia-Erzegovina 5
CZ - Repubblica Ceca 5
JM - Giamaica 5
KZ - Kazakistan 5
PS - Palestinian Territory 5
TW - Taiwan 5
AZ - Azerbaigian 4
GT - Guatemala 4
NP - Nepal 4
PE - Perù 4
RS - Serbia 4
TH - Thailandia 4
DZ - Algeria 3
EE - Estonia 3
EU - Europa 3
MD - Moldavia 3
MU - Mauritius 3
SN - Senegal 3
UY - Uruguay 3
BY - Bielorussia 2
GN - Guinea 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
MN - Mongolia 2
MT - Malta 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
SI - Slovenia 2
SM - San Marino 2
TT - Trinidad e Tobago 2
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
Totale 122.419
Città #
Cagliari 94.220
Uta 5.293
Amsterdam 1.079
Singapore 1.026
Fairfield 921
Woodbridge 846
Ashburn 842
Chandler 596
Houston 577
Boardman 569
San Jose 484
Ann Arbor 444
Dallas 427
Jacksonville 391
Wilmington 385
Seattle 360
Nyköping 340
Cambridge 293
Beijing 283
Milan 255
Rome 245
Helsinki 198
Hong Kong 195
Los Angeles 173
Boston 155
Hefei 147
Council Bluffs 139
Lauterbourg 132
Ho Chi Minh City 127
Nanjing 126
The Dalles 122
Dearborn 112
Santa Clara 105
New York 83
Hanoi 82
Buffalo 80
Dong Ket 80
Shanghai 73
Seoul 63
San Diego 61
Redwood City 54
Padova 49
Shenyang 48
Guangzhou 46
São Paulo 46
Charleston 44
Frankfurt am Main 44
Nanchang 38
Turin 37
Bari 36
Changsha 36
Verona 36
Toronto 34
Nuremberg 33
Palermo 32
London 31
Orem 30
Naples 29
Sassari 29
Washington 29
Florence 27
Hebei 27
Jiaxing 26
Norwalk 26
Redondo Beach 26
Tianjin 25
Atlanta 24
Bologna 24
Chicago 24
Munich 24
Johannesburg 22
Stockholm 21
Brooklyn 20
Orange 20
Pune 20
Jinan 19
Zhengzhou 19
Baghdad 18
Sydney 18
Warsaw 18
Phoenix 17
Rio de Janeiro 17
Tokyo 17
Auburn Hills 16
Da Nang 16
Hangzhou 16
Ningbo 16
San Francisco 16
Columbus 14
Genoa 14
Haiphong 14
Manchester 14
Montreal 14
Mumbai 14
Brescia 13
Catania 13
Chennai 13
Denver 13
Parma 13
Perugia 13
Totale 113.631
Nome #
Child and Adolescent Behavior Inventory (CABI): Standardization for age 6-17 years and first clinical application 2.082
Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study 1.879
Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder 1.844
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate 1.699
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine 1.637
Practitioner Review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder 1.613
Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence 1.597
Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale 1.562
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 1.514
Cognitive training for attention-deficit/hyperactivity disorder: Meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials 1.500
Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD) 1.481
Development and psychometric properties of the Suicidality: Treatment Occurring in Paediatrics (STOP) Suicidality Assessment Scale (STOP-SAS) in children and adolescents 1.461
Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives 1.459
The Italian autism network (ITAN): A resource for molecular genetics and biomarker investigations 1.413
Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe 1.394
Effects of methylphenidate on height in ADHD children. The monitoring of bone age within the ADDUCE project 1.362
The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles 1.314
Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder 1.294
Corrigendum: Child and adolescent behavior inventory (CABI): A new instrument for epidemiological studies and pre-clinical evaluation 1.292
Effects of long-term methylphenidate use on growth and blood pressure: Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) 1.262
ADHD and hyperkinetic disorder 1.245
ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group 1.241
Re-thinking treatment targets in child and adolescent psychiatry 1.208
null 1.154
Pediatric acute-onset neuropsychiatric syndrome: A data mining approach to a very specific constellation of clinical variables 1.141
Psychosocial risk factors for suicidality in children and adolescents 1.085
CRS-R. Conners’ Rating Scales. Revised. Manuale 1.055
null 1.045
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome 1.036
Methylphenidate long-term effects on psychiatric outcomes in a Sardinian ADHD population: preliminary results from the prospective ADDUCE project 1.023
null 980
A neurodevelopment approach for a transitional model of early onset schizophrenia 968
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies 934
Artificial neural networks analysis of polysomnographic and clinical features in pediatric acute-onset neuropsychiatric syndrome (Pans): From sleep alteration to “brain fog” 929
Metabolomic Characterization of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) 854
Systematic Review and Meta-analysis: Screening Tools for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents 851
Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: A systematic review of head-to-head studies[ BMC Psychiatry. (2013)13, 237] 811
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 800
Prevalence and correlates of mental disorders among adolescents in Italy: The PrISMA Study 798
Profili cognitivi e disturbi psicopatologici. Evidenze neurobiologiche, diagnosi, trattamento 792
Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial 768
null 754
null 750
Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis 735
Unbalanced risk-benefit analysis of ADHD drugs – Authors' reply 726
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 715
Neuropsychological characterization of aggressive behavior in children and adolescents with cd/odd and effects of single doses of medications: The protocol of the matrics_wp6-1 study 714
Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children 706
null 699
null 689
The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG) 689
null 675
The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication? 675
null 665
Vortioxetine for Major Depressive Disorder in Adolescents: 12-Week Randomized, Placebo-Controlled, Fluoxetine-Referenced, Fixed-Dose Study 663
null 658
null 632
Increased Response-Time Variability Across Different Cognitive Tasks in Children With ADHD 627
The poor outcome of conduct disorders: a need for innovative, more effective therapeutic interventions 627
Eziologia 616
null 603
Clinical characteristics, neuroimaging findings, and neuropsychological functioning in attention-deficit hyperactivity disorder: Sex differences 598
null 595
Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial 595
null 588
null 581
null 581
A crucial role for basic emotion awareness in the development of emotion regulation? 572
The neuropsychological characterization of aggressive behaviour in children and adolescents with CD/ODD: preliminary results from a multicentric case-control study (MATRICS_consortium) 571
Association of Risk of Suicide Attempts With Methylphenidate Treatment 568
null 568
null 564
Methylphenidate effects on height and bone age in ADHD children. 24 month follow up within the prospective ADDUCE project 563
null 549
EFFICACY STUDY OF AN OMEGA-3/6 COMBINATION FOR MILD- TO MODERATE-INATTENTIVE ADHD: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN ITALIAN CHILDREN 542
null 536
Management and treatment of attention-deficit/hyperactivity disorder 532
I Disturbi depressivi in età evolutiva 531
Use of atomoxetine in patients with attention-deficit hyperactivity disorder and comorbid conditions 527
A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents 522
null 519
null 517
The MTA at 8 514
Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design 508
null 506
Non-pharmacological interventions for Attention-Deficit/Hyperactivity Disorder: Systematic review and meta-analyses of randomised controlled trials of dietary and psychological treatments 505
null 501
null 501
null 497
SRS Social Responsiveness Scale di John N. Constantino e Christian P. Grube 494
European clinical guidelines for hyperkinetic disorder - first upgrade 493
Plasma poly-unsatured fatty acids profile in children with inattentive ADHD - preliminary results of an efficacy Italian study with omega 3/6 492
null 491
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review 491
null 477
null 467
Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges. 454
null 444
Face and emotion recognition in children with ADHD and autism spectrum disorders: effects of methylphenidate 437
Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder 435
Totale 85.421
Categoria #
all - tutte 181.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 181.539


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.322 0 0 0 0 0 0 0 0 0 590 483 1.249
2021/20227.717 573 518 324 892 763 432 371 602 813 872 740 817
2022/202314.499 1.096 1.876 1.615 1.101 1.067 1.151 670 1.949 962 856 1.497 659
2023/202416.961 829 681 632 1.058 1.953 2.626 2.791 1.014 844 1.224 1.784 1.525
2024/202533.367 5.755 8.871 5.369 4.342 2.223 1.915 1.670 232 420 1.380 581 609
2025/20268.683 678 333 998 776 851 908 1.366 817 741 1.215 0 0
Totale 122.938